Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China flag China · Delayed Price · Currency is CNY
6.12
-0.25 (-3.92%)
May 21, 2026, 3:04 PM CST

SHE:300289 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
591.91566.02574.27565.02798.81928.6
Trading Asset Securities
320.91336.75316.14290.29--
Cash & Short-Term Investments
912.82902.77890.41855.32798.81928.6
Cash Growth
1.21%1.39%4.10%7.07%-13.98%163.41%
Accounts Receivable
89.1192.3299.02149.76184.48232.4
Other Receivables
2.0412.8819.562.46.055.67
Receivables
91.15105.2118.58152.16190.52238.08
Inventory
88.0688.7289.4588.2897.44102.48
Other Current Assets
16.535.368.719.9323.739.96
Total Current Assets
1,1091,1021,1071,1061,1111,279
Property, Plant & Equipment
369.62373.7402.3427.68458.68474.96
Long-Term Investments
0.9510.7211.1723.6620.91.01
Goodwill
73.5373.5373.53144.66159.54190.07
Other Intangible Assets
2020.9825.1728.7433.8937.74
Long-Term Accounts Receivable
-7.421.17---
Long-Term Deferred Tax Assets
40.6841.0746.9343.0635.5227.95
Long-Term Deferred Charges
5.795.612.0217.2324.5626.15
Other Long-Term Assets
145.27141.1142.99147.69156.22311.41
Total Assets
1,7641,7761,8221,9382,0002,348
Accounts Payable
20.8720.7219.7932.8718.4736.32
Accrued Expenses
0.638.038.2117.5631.3425.8
Current Portion of Long-Term Debt
3.11-----
Current Portion of Leases
-3.044.114.293.733.31
Current Income Taxes Payable
4.661.561.042.1722.08
Current Unearned Revenue
10.6110.3810.2710.867.918.2
Other Current Liabilities
39.374337.7838.6389.57103.49
Total Current Liabilities
79.2586.7381.2106.38153.01179.21
Long-Term Leases
0.391.160.724.658.129.82
Long-Term Unearned Revenue
13.9914.0914.5715.518.3219.07
Long-Term Deferred Tax Liabilities
2.82.816.676.456.713.01
Other Long-Term Liabilities
0.660.660.680.7933.19159.19
Total Liabilities
97.1105.46103.84133.77219.35370.3
Common Stock
544.01544.01544.01544.01544.01544.01
Additional Paid-In Capital
610.81610.81610.81610.81610.81651.39
Retained Earnings
480.32484.29507.28587.82572.48639.63
Total Common Equity
1,6351,6391,6621,7431,7271,835
Minority Interest
32.1531.6256.4861.9953.16143.08
Shareholders' Equity
1,6671,6711,7191,8051,7801,978
Total Liabilities & Equity
1,7641,7761,8221,9382,0002,348
Total Debt
3.54.24.838.9511.8413.13
Net Cash (Debt)
909.32898.57885.58846.37786.97915.47
Net Cash Growth
1.24%1.47%4.63%7.55%-14.04%192.03%
Net Cash Per Share
1.671.651.631.561.402.04
Filing Date Shares Outstanding
544.16544.01544.01544.01544.01544.01
Total Common Shares Outstanding
544.16544.01544.01544.01544.01544.01
Working Capital
1,0291,0151,026999.3957.491,100
Book Value Per Share
3.003.013.063.203.183.37
Tangible Book Value
1,5421,5451,5631,5691,5341,607
Tangible Book Value Per Share
2.832.842.872.882.822.95
Buildings
-479.36486.27495.09488.24487.72
Machinery
-288.13281.56253.19245.25231.03
Construction In Progress
-2.090.580.526.4-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.